UNSPSC 51123000: Antiarrythmic alkaloids

This classification denotes organic nitrogenous bases, which chemists usually extract from animal and vegetable sources (and thereafter synthesize the same), substances which called alkaloids, that prevent or treat irregular heartbeat, disturbances of normal rhythmic heart beating, or normal operation of myocardial contraction, thus the term ANTIARRYTHMIC ALKALOIDS.

UNSPSC 51123000 Antiarrhythmic alkaloids is a Class code that describes emergency medical medications purchased by state and local public safety agencies, specifically antiarrhythmic and cardiac-support drugs used in advanced life support protocols. State and local procurement under this code centers on medications such as adenosine, diltiazem, epinephrine, and labetalol — pharmaceuticals administered by fire rescue and emergency medical services during cardiac events and other critical care situations. Issuing bodies are primarily municipal fire and rescue departments, which source these medications through city purchasing offices. Vendors must meet stringent compliance requirements including product expiration guarantees (typically nine months or longer from acceptance), rapid delivery windows (often ten calendar days or less), defect warranties covering a full year post-delivery, and comprehensive safety documentation per OSHA Hazard Communication Standards.

The City of Tampa's Purchasing Department posted an IFB (Bid No. 26P00188) for Advanced Life Support Medications on April 24, 2026, with a response deadline of April 8, 2026, soliciting four medication line items totaling approximately 3,530 units (370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials) with an estimated contract value of $40,000.00. The solicitation included a Small Local Business Enterprise sheltered market designation offering a 5 percent bid discount for SLBE participation, not to exceed $10,000. The contract term runs one year from the effective award date with two optional one-year renewals and unilateral extension provisions for up to three additional 30-day periods. Award was to be made to the lowest responsive, responsible bidder within 120 days of bid opening. The source provides only this single recent opportunity and does not establish a pattern of activity across other jurisdictions or states.